Skip to main content

Table 1 Characteristics of patients and surgery

From: Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy

 

Group S (n = 28)

Group NS (n = 28)

Age (years)

42.4 ± 14.3

40.6 ± 13.5

Gender (M/F)

15/13

16/12

Weight (Kg)

76.7 ± 18.8

72.9 ± 11.2

Height (cm)

168.3 ± 13.6

166.3 ± 12.1

BMI (Kg/m2)

26.9 ± 5.7

26.9 ± 6.2

ASA Status

1

2

3

14

11

3

13

13

2

Surgery time (min)

109.1 ± 84.2

100.0 ± 48.9

Anesthesia time (min)

142.4 ± 91.8

133.0 ± 52.7

Total rocurunium (mg)

104.6 ± 61.5

93.8 ± 21.1

Total rocuronium/h (mg/h)

76.6 ± 45.5

65.8 ± 35.9

Total rocuronium/Kg (mg/Kg)

1.4 ± 0.8

1.3 ± 0.4

Smax (mA)

38.0 ± 14.6

39.9 ± 10.9

Temperature at end of surgery (°C)

36.1 ± 0.5

35.8 ± 0.6

  1. Data are means ± SD or numbers
  2. S Sugammadex, NS Neostigmine and Sugammadex, M Male, F Female, Smax Supramaximal current